5/3/24 5/3/24

Challenges of the 2022 Medicare Fee Schedule for Pathology in Clinical Diagnostic Labs

Read More

5/3/24 5/3/24

Policies In Place To Safeguard Patient Confidentiality In Laboratory Billing

Read More

5/3/24 5/3/24

The Impact of Cost Changes on Billing and Reimbursement in Clinical Diagnostic Labs

Read More

5/3/24 5/3/24

Improving Diagnostic Test Reimbursement Policies

Read More

5/3/24 5/3/24

Precautions For Phlebotomists During Surveillance Testing

Read More

5/3/24 5/3/24

Policies That Foster Innovation in Diagnostic Labs Despite the Valid Act

Read More

5/3/24 5/3/24

Potential Impacts of Budget Cuts on Patient Care in Diagnostic Labs

Read More

5/3/24 5/3/24

Boosting Efficiency in Clinical Diagnostic Lab Training: Practical Steps to Expedite the Process

Read More

5/3/24 5/3/24

Key Practices That Might Violate the Anti-Kickback Statute by Phlebotomy Providers

Read More

5/3/24 5/3/24

Precautions Should Be Taken When Using Billing Data For Payer Contract Negotiations

Read More

5/3/24 5/3/24

Preventive Measures to Avoid Mismanagement by a Billing Company in the Lab

Read More

5/3/24 5/3/24

Key Policies for Ensuring Regulatory Compliance in a CLIA Lab

Read More

5/3/24 5/3/24

The Best Postgraduate Courses to Consider for DCLS

Read More

5/3/24 5/3/24

Anticipated Future Developments in the Use of AI in Denial Management in Clinical Diagnostic Labs

Read More

5/3/24 5/3/24

The Impact Of Adopted Rules In Clinical Diagnostic Labs On Patient Care

Read More

5/3/24 5/3/24

Policies in Place to Maintain Transparency in the BCBSM Incentive Program for Phlebotomy

Read More

5/3/24 5/3/24

What Precautions Are Taken During Phlebotomy for Toxicology Testing

Read More

5/3/24 5/3/24

Precautions Taken During Phlebotomy in a Toxicology Lab

Read More

5/3/24 5/3/24

Potential Solutions to Overcome the Challenges Posed by the Valid Act

Read More

5/3/24 5/3/24

Ensuring Safety Measures for Lab Staff to Prevent Chemical Hazards

Read More